The Cooper Companies, Inc. (COO): one to watch?
Cheap-looking but murky — a modest guidance cut plus a canceled sale sparked a 20%+ drop that may be an overreaction, but a shareholder-rights investigation adds real uncertainty.
Fell 22% in 11 trading day(s) — now $55.29
Why COO dropped
Cooper Companies beat EPS estimates on Sept 9 Q3 2026 earnings but missed on revenue, cut full-year guidance modestly (EPS midpoint to $4.53 from $4.62, about 2%), and abandoned a long-rumored sale of its CooperSurgical unit — disappointing investors hoping for a buyout premium. Management attributed the CooperVision revenue miss to U.S. "channel inventory" destocking rather than falling end-consumer demand, which continued at steady mid-single-digit growth.
How this scored 68/100
Bar length shows how much each metric is worth — a 10-point metric is twice as wide as a 5-point one. Hover any row for what it means.
🔒 Read the full AI analysis
Create a free account to unlock the bull case and the risks for COO — plus today's other picks.
Analysis generated by SmartStonks's AI from public fundamentals and news, first flagged 2026-09-21. Research only — not financial advice.